Literature DB >> 30019203

[Revised version of the 4th edition of the WHO classification of malignant lymphomas : What is new?]

G Ott1, W Klapper2, A C Feller3, M L Hansmann4, P Möller5, H Stein6, A Rosenwald7, F Fend8.   

Abstract

After 8 years, the WHO has now published the updated version of the 4th edition of the classification of hematopoietic and lymphoid tumors. This update provides a conceptual rewrite of existing entities as well as some new provisional entities and categories, particularly among the aggressive B‑cell lymphomas. Important new diagnostic categories include the high-grade B‑cell lymphomas, the large B‑cell lymphoma with IRF4 rearrangement, and the Burkitt-like lymphoma with 11q aberrations. Of particular importance, new concepts concerning the taxonomy and classification of early lymphoid lesions or precursor lesions are included, such as the in situ follicular neoplasia or the in situ mantle cell neoplasia. In addition, the concept of indolent lymphoproliferations, such as breast-implant-associated anaplastic large cell lymphoma and the indolent T‑cell lymphoproliferative disorder of the gastrointestinal tract, has been strengthened. Finally, diagnostic criteria for existing lymphoma entities have been refined.

Entities:  

Keywords:  Biology; Classification; Lymphoma; Revised 4th edition; WHO

Mesh:

Year:  2019        PMID: 30019203     DOI: 10.1007/s00292-018-0456-4

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  2 in total

1.  Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar).

Authors:  Caterina Vacchi; Marcella Visentini; Laura Gragnani; Paolo Fraticelli; Antonio Tavoni; Davide Filippini; Francesco Saccardo; Gianfranco Lauletta; Stefania Colantuono; Fabiola Atzeni; Pietro Pioltelli; Andreina Manfredi; Milvia Casato; Anna Linda Zignego; Giuseppe Monti; Maurizio Pietrogrande; Massimo Galli; Marco Sebastiani
Journal:  Intern Emerg Med       Date:  2020-06-10       Impact factor: 3.397

2.  The associations between Deltex1 and clinical characteristics of breast cancer.

Authors:  Xiaoyi Liu; Yuwei Xian; Hongmei Xu; Meixiang Hu; Kui Che; Xiangping Liu; Haibo Wang
Journal:  Gland Surg       Date:  2021-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.